New Biologic Stelara Receives Approval In Europe For Treatment Of Moderate To Severe Plaque Psoriasis

Janssen-Cilag announced today that STELARA (ustekinumab), the first in a new class of biologics, has been approved by the European Commission for use across Europe.

The details can be read here.